News

The bispecific T-cell engager tarlatamab demonstrated favorable antitumor activity in a small cohort with small cell lung ...
McNally was speaking at the Outsourcing in Clinical Trials Europe, in Barcelona on 30 April. She said Parexel has ‘rescued’ ...
Symptoms of inflammatory bowel disease (IBD) range from diarrhea and abdominal pain to nausea, fever, loss of appetite, fatigue and, at times, rectal bleeding. No single test can confirm IBD, which ...
Download Cerba Research's new report to discover how to overcome immunogenicity and safety challenges in oncology.
Now that HHS Secretary Robert F. Kennedy Jr. oversees the vaccine database he said holds the answer to the cause of autism, ...
The answer to this inquiry is “yes” — but maybe “no.” Will confidentiality agreements shield any prior art concerns? Once ...
Q1 2025 Management View CEO Jay Duker highlighted the progress of DURAVYU, their lead program for treating wet AMD, noting ...
A Department of Health and Human Services spokesperson called the move "a radical departure from past practices." ...
Wegovy (semaglutide) could offer a new option to treat severe liver disease based on new clinical trial evidence. The GLP-1 ...
The transition from preclinical development to clinical trials is a critical, with approximately 89% of drugs failing. Nearly half of these failures stem from unexpected and unmanageable human ...
The results offer some of the first glimpses into real-world findings of the Janus kinase inhibitor in patients with ...
Trials of IFx-Hu2.0 are initiating, looking to overcome checkpoint inhibitor resistance in Merkel cell carcinoma.